12月18日，康师傅（康师傅控股，0322.HK）公告称，原首席执行官陈应让已决定退休，不再与公司续期服务合约，公司与陈应让的合约将于 2025年12月31日到期。公司现任执行董事、康师傅饮品控股有限公司（以下简称"康师傅饮品"）董事长魏宏丞将从2026年1月1日起出任公司首席 执行官。 核心管理团队迎来新老交替 据公开资料，此次退休的陈应让出生于1963年，毕业于台湾大学化学工程系。他曾在宝洁公司工作，拥有25年跨国研发管理经验，2013年2月加入 康师傅，负责研发业务。2021年1月，他出任康师傅集团CEO，并于2023年入选福布斯中国最佳CEO榜单。此次人事调整标志着康师傅核心管理团 队迎来新老交替。 目前，魏宏丞持有康师傅500万股股份及138.5万股购股权，其家庭亲属拥有公司主要股东顶新（开曼岛）控股有限公司100%的权益。 魏家"二代"全面接管康师傅 魏宏丞上任标志着康师傅结束了11年的职业经理人时代。2014年底，魏应州宣布不再担任公司首席执行官，韦俊贤自2015年1月1日起获得委任。 2019年底，韦俊贤决定退休，随后陈应让接替该职，直到今年决定不再续期。 核心管理层进一步年轻化 这一人事变动 ...

Financial Performance - Core revenue (tissue and hygiene products) decreased by 3.1% to RMB 10.5 billion in 1H2025, compared to RMB 10.8 billion in 1H2024[9] - Profit attributable to shareholders decreased by 2.6% to RMB 1.37 billion in 1H2025, compared to RMB 1.41 billion in 1H2024[9] - Overall revenue slightly decreased by 0.2% to RMB 11,808.232 million in 1H2025, from RMB 11,835.893 million in 1H2024[15] - Basic earnings per share (EPS) decreased by 2.3% to RMB 1.206 in 1H2025, from RMB 1.234 in 1H2024[15] - Interim dividend per share remained unchanged at RMB 0.70[15] Business Segments - Tissue paper revenue increased by 3.2% to RMB 7,173.7 million in 1H2025, compared to RMB 6,950.578 million in 1H2024[18] - Hygiene products revenue decreased by 14.4% to RMB 3,303.839 million in 1H2025, compared to RMB 3,858.570 million in 1H2024[18] - Other revenue increased by 29.6% to RMB 1,330.693 million in 1H2025, compared to RMB 1,026.745 million in 1H2024[18] - Tissue paper sales in e-commerce and new retail channels rose significantly by 15.1%, accounting for nearly 40.9% of overall tissue sales[44] Financial Position - Net cash increased to RMB 6.4 billion in 1H2025, from RMB 5.4 billion in 1H2024[9] - Gearing ratio decreased to 77.5% in 1H2025, from 99.1% in 1H2024[9] - E-commerce and new retail channels sales Up 7.9%, to over RMB 4.06 billion[54] ESG - The company maintained a BBB rating from MSCI ESG Rating[11, 58]